Metabolomic profile and its association with the diagnosis of prostate cancer: a systematic review
Journal of Cancer Research and Clinical Oncology · 2024
DOI: 10.1007/s00432-024-06058-w ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Cancer Research and Clinical Oncology, 2024. Verfasst von Angela Patricia Salinas Pita und 3 weiteren Autor:innen. Beteiligte Einrichtung: Program in Biomedical Sciences, Universidad del Valle, Cali, Colombia. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Metabolomics. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia, Tecnología e Innovación, University of the Valley.
Abstract (Originalsprache)
Objective
To determine the association of a metabolomic profile with the diagnosis of localized prostate cancer.
Methods
We conducted a search strategy in MEDLINE (OVID), EMBASE, LILACS, and the Cochrane Central Register of Controlled Trials (CENTRAL) from 2008 to the present. We included Clinical trials and analytical and descriptive observational studies that reported metabolite results and metabolite profiles in serum, tissue, urine, and seminal fluid. All studies used metabolomic techniques such as MS and MRI to identify patients with localized prostate cancer compared with patients without cancer. We used QUADAS 2 to assess the risk of bias.
Results
We found 1248 studies with the search strategy. Finally, 14 case–control studies were included. Serum was the primary sample to identify the metabolites. Low concern was found regarding applying the index test and the reference standard in assessing the risk of bias. The metabolites of interest associated with establishing a metabolomic profile in the diagnosis of localized prostate cancer were amino acids, lipids, androgens, estrogens, nucleotides, and histidine metabolism.
Conclusion
Disturbances in the metabolism of fatty acids, amino acids, nucleotides, and steroid hormones were identified, suggesting the presence of localized prostate cancer. Importantly, serum samples showed an increase in amino acid levels. Glutamate and aspartic acid stand out among the amino acids that register high levels. In addition, glycine and serine were consistently decreased metabolites in the three kinds of biological samples analyzed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Program in Biomedical Sciences, Universidad del Valle, Cali, Colombia.
- Department of Physiological Sciences, Basic Science School, Nutrition Group, Universidad del Valle, Cali, Colombia.
- Division of Urology/Urooncology, Department of Surgery, School of Medicine, Universidad del Valle, Calle 4 B # 36-00, Cali, Colombia. herney.garcia@correounivalle.edu.co.
Förderung
- Ministerio de Ciencia, Tecnología e Innovación
- University of the Valley
Zitieren
APA
Salinas Pita, A. P., Mosquera Escudero, M., Jiménez-Charris, E., & García-Perdomo, H. A. (2024). Metabolomic profile and its association with the diagnosis of prostate cancer: a systematic review. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-024-06058-w
Vancouver
Salinas Pita AP, Mosquera Escudero M, Jiménez-Charris E, García-Perdomo HA. Metabolomic profile and its association with the diagnosis of prostate cancer: a systematic review. Journal of Cancer Research and Clinical Oncology. 2024. doi:10.1007/s00432-024-06058-w
BibTeX
@article{SalinasPita2024,
author = {Salinas Pita, Angela Patricia and Mosquera Escudero, Mildrey and Jiménez-Charris, Eliecer and García-Perdomo, Herney Andrés},
title = {Metabolomic profile and its association with the diagnosis of prostate cancer: a systematic review},
journal = {Journal of Cancer Research and Clinical Oncology},
year = {2024},
doi = {10.1007/s00432-024-06058-w}
}
EUVIMED